Developer docs
API playgroundTry for free, no card

Search company profiles

Emblem

Full company profile

uuid000674v

Namestring
Emblem
Legal namestring
Emblem Cannabis
Websiteurl
emblemcorp.com
Company typeenum
Public
Founded yearint
2008
Descriptiontext

Emblem Cannabis Corporation is a Canadian Health Canada-licensed producer and distributor of medical cannabis, headquartered in Montreal, Quebec, and operating as a wholly-owned subsidiary of Red White & Bloom Brands Inc. The company cultivates and processes full-spectrum cannabis extracts and hang-dried, hand-manicured dried flower, and sells these products alongside vaporizer devices and specialized items such as Assuage suppositories directly to registered patients through an online marketplace at shop.emblemcannabis.com, with nationwide shipping averaging two days. Patient registration is facilitated through a partnership with Canabo Medical Clinic, which routes prospective patients to cannabis-trained healthcare practitioners for medical authorizations, and the company supports a Compassionate Pricing Program plus 100% Veterans Affairs coverage.

The company's revenue model is transactional, combining direct-to-patient medical sales with wholesale and retail distribution. Emblem is publicly traded on the TSX Venture Exchange (CVE:EMC) and OTCMKTS (EMMBF), with a market capitalization of approximately CDN$245.45 million and a PE ratio of -9.89, reflecting ongoing losses typical of the Canadian medical cannabis sector. On June 8, 2026, Emblem closed a CDN$5,501,311 acquisition of Ayurcann Holdings' Health Canada-licensed manufacturing operations through a court-supervised CCAA insolvency proceeding, adding a formulation and packaging facility in Pickering, Ontario, three nationally recognized consumer brands (Fuego, Xplor, Happy & Stoned), over 90 SKUs, and distribution across approximately 2,500 retail locations in Canada. Leadership includes CFO Alexander Stojanovic and COO Daniel David Saperia; the company employs between 51 and 100 people.

Short descriptiontext

Emblem Cannabis is a Canadian Health Canada-licensed producer and distributor of medical cannabis extracts, dried flower, and vaporizer products sold directly to registered patients nationwide. Following its June 2026 acquisition of Ayurcann, it also distributes Fuego, Xplor, and Happy & Stoned brands through roughly 2,500 Canadian retail locations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis, cannabis cultivation, cannabis extracts, licensed producer, dried flower
Industry2 codes
1Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
CodeCRANAFAHPrimaryYes
2Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.)
CodeCRANAFAJPrimaryNo
NAICS code1 code
  • Health and Personal Care Retailers456
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Medical Cannabis
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Cannabis Product Sales
TypeTransaction Fee
Description

Emblem generates revenue through direct sales of medical cannabis products including dried flower, extracts, oils, and vaporizer products to registered patients. Patients purchase through an online marketplace after obtaining medical authorization. Revenue is transactional per order with recurring customer relationships.

emblemcannabis.com
2Acquired Brand Portfolio Revenue
TypeTransaction Fee
Description

Following the Ayurcann acquisition, Emblem now owns leading vape and pre-roll brands (Fuego, Xplor, Happy & Stoned) with over 90 SKUs distributed through approximately 2,500 retail locations across Canada, creating additional revenue streams through both B2B wholesale and direct-to-patient channels.

globenewswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Patient pricing program with compassionate rates
ModelOtherBilling cadencePay-as-you-go
Notes

Compassionate Pricing Programs available for patients in need; 100% Veterans Affairs coverage; exclusive discounts for registered patients

emblemcannabis.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Emblem is a Health Canada-licensed producer and distributor of medical cannabis operating an online marketplace where registered patients can order full-spectrum extracts, dried flower, vaporizers, and specialized products. The company pairs cannabis sales with award-winning patient care, same-day registration, and fast free shipping across Canada. Following the June 2026 acquisition of Ayurcann's manufacturing operations, Emblem also distributes the Fuego, Xplor, and Happy & Stoned vape and pre-roll brands through approximately 2,500 retail locations nationwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Average 2-day shipping across Canada
+2 more records
Product overview1 text field

Emblem Cannabis operates as a medical cannabis provider offering a platform-based online marketplace with multiple product categories. The core offering includes proprietary medical cannabis products (full-spectrum extracts and dried flower), supplemented by vaporizer devices (Arizer Air II, Arizer ArGo, Arizer Solo 2) and specialized products like Assuage suppositories. Following the June 2026 acquisition of Ayurcann's operations, the portfolio expanded to include three nationally recognized acquired brands—Fuego and Xplor (vape products) and Happy & Stoned (pre-roll products)—with over 90 combined SKUs distributed through approximately 2,500 retail locations, along with a licensed manufacturing facility in Pickering, Ontario.

Product and service1 record
1Medical Cannabis Products
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Canabo Medical Clinic is a cannabis education centre and cannabinoid clinic that partners with Emblem to facilitate patient assessments. The partnership enables patients to schedule appointments with healthcare practitioners who can assess their eligibility for medical cannabis access and provide the required medical documentation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership with GreenSpace Brands for CBD product development, expanding Emblem's product offerings in the CBD consumer market segment.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of Canada's largest licensed producers with a strong medical cannabis platform (Aurora Med), directly comparable to Emblem as a publicly traded Canadian LP serving registered patients across Canada.

TypeDirect peer
Description

Publicly traded Canadian LP focused on both medical and recreational cannabis with branded dried flower and vape products (e.g., SHRED, Tremclad), similar in scale and product mix to Emblem's acquired Fuego/Xplor portfolio.

TypeDirect peer
Description

Major global cannabis producer with significant Canadian medical and recreational operations, comparable to Emblem as a publicly traded LP distributing through nationwide retail channels and direct patient platforms.

TypeDirect peer
Description

Canada's largest LP and medical cannabis provider (Spectrum Therapeutics), operating across cultivation, extraction, and branded consumer goods—overlapping with Emblem's full-stack, multi-brand model.

TypeDirect peer
Description

Canadian-licensed cannabis producer with branded recreational and medical offerings, comparable to Emblem as a publicly traded Canadian LP pursuing both patient-direct and retail distribution.

TypeDirect peer
Description

Multi-state and Canadian cannabis operator with medical patient platforms (e.g., Apothecarium) and branded wholesale products, analogous to Emblem's mix of direct-to-patient and ~2,500 retail reach.

TypeDirect peer
Description

Canadian-listed greenhouse operator that converted into a major cannabis LP (Pure Sunfarms), comparable to Emblem as a mid-cap public Canadian producer with controlled-environment cultivation expertise.

TypeEmerging player
Description

Canadian cannabis retail-led operator with a large brick-and-mortar store footprint and consumer-brand portfolio, comparable to Emblem on the retail distribution and branded consumer side rather than pure cultivation.

TypeOthers
Description

Emblem's publicly traded parent company operating a multi-state/province cannabis portfolio in the U.S. and Canada—relevant as the controlling shareholder shaping Emblem's capital allocation and strategic direction.

TypeEmerging player
Description

Israel/Canada-based medical cannabis operator with a direct-to-patient model, analogous in scale and medical-patient orientation to Emblem's core legacy business pre-Ayurcann.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Emblem

Medical Cannabisemblemcorp.com

Emblem Cannabis is a Canadian Health Canada-licensed producer and distributor of medical cannabis extracts, dried flower, and vaporizer products sold directly to registered patients nationwide. Following its June 2026 acquisition of Ayurcann, it also distributes Fuego, Xplor, and Happy & Stoned brands through roughly 2,500 Canadian retail locations.

What Emblem does

Emblem Cannabis Corporation is a Canadian Health Canada-licensed producer and distributor of medical cannabis, headquartered in Montreal, Quebec, and operating as a wholly-owned subsidiary of Red White & Bloom Brands Inc. The company cultivates and processes full-spectrum cannabis extracts and hang-dried, hand-manicured dried flower, and sells these products alongside vaporizer devices and specialized items such as Assuage suppositories directly to registered patients through an online marketplace at shop.emblemcannabis.com, with nationwide shipping averaging two days. Patient registration is facilitated through a partnership with Canabo Medical Clinic, which routes prospective patients to cannabis-trained healthcare practitioners for medical authorizations, and the company supports a Compassionate Pricing Program plus 100% Veterans Affairs coverage.

The company's revenue model is transactional, combining direct-to-patient medical sales with wholesale and retail distribution. Emblem is publicly traded on the TSX Venture Exchange (CVE:EMC) and OTCMKTS (EMMBF), with a market capitalization of approximately CDN$245.45 million and a PE ratio of -9.89, reflecting ongoing losses typical of the Canadian medical cannabis sector. On June 8, 2026, Emblem closed a CDN$5,501,311 acquisition of Ayurcann Holdings' Health Canada-licensed manufacturing operations through a court-supervised CCAA insolvency proceeding, adding a formulation and packaging facility in Pickering, Ontario, three nationally recognized consumer brands (Fuego, Xplor, Happy & Stoned), over 90 SKUs, and distribution across approximately 2,500 retail locations in Canada. Leadership includes CFO Alexander Stojanovic and COO Daniel David Saperia; the company employs between 51 and 100 people.

Emblem firmographics

Firmographics
Name
Emblem
Legal name
Emblem Cannabis
Website
https://emblemcorp.com
Company type
Public
Founded year
2008
Operating status
Operating
Headcount range
51–100 employees
Short description
Emblem Cannabis is a Canadian Health Canada-licensed producer and distributor of medical cannabis extracts, dried flower, and vaporizer products sold directly to registered patients nationwide. Following its June 2026 acquisition of Ayurcann, it also distributes Fuego, Xplor, and Happy & Stoned brands through roughly 2,500 Canadian retail locations.
Ownership category
akta.pro rank

Emblem industry classification

Industry
Product category
Medical Cannabis
NAICS
Health and Personal Care Retailers (456)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH)
akta.pro secondary industry
Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)

Keywords

  • Medical cannabis
  • Cannabis cultivation
  • Cannabis extracts
  • Licensed producer
  • Dried flower

Where Emblem is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Emblem business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

  1. Medical Cannabis Product Sales: Emblem generates revenue through direct sales of medical cannabis products including dried flower, extracts, oils, and vaporizer products to registered patients. Patients purchase through an online marketplace after obtaining medical authorization. Revenue is transactional per order with recurring customer relationships.
  2. Acquired Brand Portfolio Revenue: Following the Ayurcann acquisition, Emblem now owns leading vape and pre-roll brands (Fuego, Xplor, Happy & Stoned) with over 90 SKUs distributed through approximately 2,500 retail locations across Canada, creating additional revenue streams through both B2B wholesale and direct-to-patient channels.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPatient pricing program with compassionate rates

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Emblem product offering

Product offering

Core offering

Emblem is a Health Canada-licensed producer and distributor of medical cannabis operating an online marketplace where registered patients can order full-spectrum extracts, dried flower, vaporizers, and specialized products. The company pairs cannabis sales with award-winning patient care, same-day registration, and fast free shipping across Canada. Following the June 2026 acquisition of Ayurcann's manufacturing operations, Emblem also distributes the Fuego, Xplor, and Happy & Stoned vape and pre-roll brands through approximately 2,500 retail locations nationwide.

Product overview

Emblem Cannabis operates as a medical cannabis provider offering a platform-based online marketplace with multiple product categories. The core offering includes proprietary medical cannabis products (full-spectrum extracts and dried flower), supplemented by vaporizer devices (Arizer Air II, Arizer ArGo, Arizer Solo 2) and specialized products like Assuage suppositories. Following the June 2026 acquisition of Ayurcann's operations, the portfolio expanded to include three nationally recognized acquired brands—Fuego and Xplor (vape products) and Happy & Stoned (pre-roll products)—with over 90 combined SKUs distributed through approximately 2,500 retail locations, along with a licensed manufacturing facility in Pickering, Ontario.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Products

Quantifiable outcome

  • Average 2-day shipping across Canada
  • +2 more outcomes

Companies that use Emblem

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Emblem technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Emblem partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Canabo Medical CliniccoreStrategic or Co-development PartnerCanabo Medical Clinic is a cannabis education centre and cannabinoid clinic that partners with Emblem to facilitate patient assessments. The partnership enables patients to schedule appointments with healthcare practitioners who can assess their eligibility for medical cannabis access and provide the required medical documentation.
  • GreenSpace BrandsminorStrategic or Co-development PartnerStrategic partnership with GreenSpace Brands for CBD product development, expanding Emblem's product offerings in the CBD consumer market segment.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Emblem competitors and assessment

Company assessment

Direct peers

  • Aurora Cannabis: One of Canada's largest licensed producers with a strong medical cannabis platform (Aurora Med), directly comparable to Emblem as a publicly traded Canadian LP serving registered patients across Canada.
  • OrganiGram Holdings: Publicly traded Canadian LP focused on both medical and recreational cannabis with branded dried flower and vape products (e.g., SHRED, Tremclad), similar in scale and product mix to Emblem's acquired Fuego/Xplor portfolio.
  • Tilray Brands: Major global cannabis producer with significant Canadian medical and recreational operations, comparable to Emblem as a publicly traded LP distributing through nationwide retail channels and direct patient platforms.
  • Canopy Growth Corporation: Canada's largest LP and medical cannabis provider (Spectrum Therapeutics), operating across cultivation, extraction, and branded consumer goods—overlapping with Emblem's full-stack, multi-brand model.
  • Cronos Group: Canadian-licensed cannabis producer with branded recreational and medical offerings, comparable to Emblem as a publicly traded Canadian LP pursuing both patient-direct and retail distribution.
  • TerrAscend Corp. Multi-state and Canadian cannabis operator with medical patient platforms (e.g., Apothecarium) and branded wholesale products, analogous to Emblem's mix of direct-to-patient and ~2,500 retail reach.
  • Village Farms International: Canadian-listed greenhouse operator that converted into a major cannabis LP (Pure Sunfarms), comparable to Emblem as a mid-cap public Canadian producer with controlled-environment cultivation expertise.

Emerging players

  • High Tide Inc. Canadian cannabis retail-led operator with a large brick-and-mortar store footprint and consumer-brand portfolio, comparable to Emblem on the retail distribution and branded consumer side rather than pure cultivation.
  • IM Cannabis: Israel/Canada-based medical cannabis operator with a direct-to-patient model, analogous in scale and medical-patient orientation to Emblem's core legacy business pre-Ayurcann.

Others

  • Red White & Bloom Brands Inc. Emblem's publicly traded parent company operating a multi-state/province cannabis portfolio in the U.S. and Canada—relevant as the controlling shareholder shaping Emblem's capital allocation and strategic direction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Emblem social profiles

Digital presence

Emblem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Emblem leadership team

Management profile

Number of profiles

Profiles2 records

Emblem subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Emblem funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Emblem M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emblem

What does Emblem do?

Emblem is a Health Canada-licensed producer and distributor of medical cannabis operating an online marketplace where registered patients can order full-spectrum extracts, dried flower, vaporizers, and specialized products. The company pairs cannabis sales with award-winning patient care, same-day registration, and fast free shipping across Canada. Following the June 2026 acquisition of Ayurcann's manufacturing operations, Emblem also distributes the Fuego, Xplor, and Happy & Stoned vape and pre-roll brands through approximately 2,500 retail locations nationwide.

Is Emblem a public or private company?

Emblem is a public company. It is classified as corporate owned and is currently operating.

When was Emblem founded?

Emblem was founded in 2008. It employs 51 to 100 people.

Where is Emblem based?

Emblem is headquartered in Toronto, Canada, in the North America region.

How does Emblem make money?

Two revenue lines are on record. Medical Cannabis Product Sales are the primary driver. The others are acquired Brand Portfolio Revenue.

Who are Emblem's main competitors?

Direct peers on record are Aurora Cannabis, OrganiGram Holdings, Tilray Brands, Canopy Growth Corporation, Cronos Group, TerrAscend Corp. and Village Farms International. Emerging players are High Tide Inc. and IM Cannabis. Red White & Bloom Brands Inc. is listed as an others.

Does Emblem have an API?

No public API is recorded for Emblem.

What industry is Emblem in?

Emblem's product category is Medical Cannabis. Its primary akta.pro industry code is CRANAFAH, Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise), with a secondary code of CRANAFAJ, Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.). Its NAICS code is 456 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Markets DailyEmblem (CVE:EMC) Stock Price Passes Below 50 Day Moving Average – Should You Sell?Emblem Corp's shares fell below its 50-day moving average on Thursday, trading at $1.84 against a 50-day average of $1.88. The company, which produces medical cannabis in Canada, has a market cap of $245.45 million and a P/E ratio of -9.89.Ticker ReportEmblem (CVE:EMC) Stock Crosses Below Fifty Day Moving Average – Time to Sell?Shares of Emblem Corp (CVE:EMC) crossed below its fifty-day moving average of $1.88 during Wednesday trading, reaching a low of $1.84 with a volume of 597,714 shares. The company, which produces and distributes medical cannabis in Canada, currently holds a market capitalization of $245.45 million and a negative P/E ratio of -9.89.Markets DailyEmblem (OTCMKTS:EMMBF) Stock Passes Below 50 Day Moving Average – Here’s What HappenedEmblem Corp's stock traded below its 50-day moving average during Monday's trading session, reaching as low as $1.36 and last traded at $1.40. The company is a Canadian licensed producer of medical cannabis with operations in Quebec, covering the entire supply chain from genetics research to product development. The stock's decline could indicate short-term market fluctuations or investor sentiment.GlobeNewswireRed White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Completes Acquisition of Ayurcann's Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded NatRed White & Bloom Brands' wholly-owned subsidiary Emblem Cannabis Corporation has successfully closed the acquisition of Ayurcann's Health Canada-licensed manufacturing operations, including the nationally recognized Fuego, Xplor, and Happy & Stoned brands, through a court-supervised insolvency proceeding under the Companies' Creditors Arrangement Act. The transaction was valued at CDN$5,501,311, comprising a debt release of CDN$2,101,075 and CDN$3,400,236 in cash consideration, and includes a licensed formulation and manufacturing facility in Pickering, Ontario, over 90 SKUs distributed through approximately 2,500 retail locations across Canada. The company expects the acquisition to be immediately accretive to both revenue and EBITDA, strengthening its position in the Canadian cannabis market while creating a foundation to expand the acquired brands into additional legal cannabis markets.Defense WorldEmblem (OTCMKTS:EMMBF) Stock Crosses Above Fifty Day Moving Average – Here’s What HappenedEmblem Corp's stock (OTCMKTS:EMMBF) crossed above its 50-day moving average during trading on Friday, reaching a high of $1.4491 with a volume of 156,200 shares. The stock currently trades at $1.40, with both its 50-day and 200-day moving averages sitting at $1.40. Emblem Corp is a Canadian licensed producer of medical cannabis headquartered in Montreal, Quebec, operating greenhouse cultivation and extraction facilities.Defense WorldEmblem (CVE:EMC) Share Price Passes Below 200-Day Moving Average – Time to Sell?Emblem Corp (CVE:EMC) shares crossed below their 200-day moving average during Friday trading, reaching as low as $1.84 with a volume of 597,714 shares. The company has a market capitalization of $245.45 million and a PE ratio of -9.89, reflecting ongoing losses in the medical cannabis sector. Emblem Corp operates as a Canadian medical cannabis producer and distributor, with a strategic partnership with GreenSpace Brands for CBD product development.PR NewswireAphria Inc. Announces Fourth Quarter and Fiscal Year 2020 ResultsAphria Inc. reported fiscal year 2020 net revenue of $543.3 million, a 129% increase from $237.1 million in 2019, with Q4 net revenue of $152.2 million representing an 18% year-over-year increase. The company posted a Q4 net loss of $98.8 million due to a $64 million non-cash impairment related to COVID-19 impacts on international operations, though adjusted EBITDA from cannabis operations improved 55% to $9.3 million quarter-over-quarter. Aphria also established a $100 million at-the-market equity program, received EU GMP certification at its Malta subsidiary, and settled an outstanding dispute with Emblem Cannabis Corporation and Aleafia Health Inc.PR NewswireAphria Inc. Statement Regarding Emblem Corp. Wholesale Cannabis Supply AgreementAphria Inc. issued a statement on October 8, 2019 expressing disappointment over Aleafia Health Inc.'s termination of a wholesale cannabis supply agreement with Emblem Corp. The company noted it had made good faith efforts to continue the agreement as a large shareholder of Aleafia, but the termination frees up supply to service its own high-demand brands. Aphria indicated it will enter a 30-day negotiation period and intends to vigorously defend itself if Aleafia initiates a formal damages claim.GlobeNewswireAleafia Health Commences Trading on the Toronto Stock ExchangeAleafia Health's common shares began trading on the Toronto Stock Exchange under the symbol ALEF on March 19, 2019. The company also became a reporting issuer in Ontario, and previously listed Emblem Corp. warrants remain exercisable into 0.8377 of a common share.PR NewswireCannabis Market Continues to Grow as More States Eye LegalizationThe legal cannabis market is experiencing sustained growth as North America accounts for over 90% of global sales, with market valuation projected to grow from USD 9.3 billion in 2016 to USD 146.4 billion by 2025 at a 34.6% CAGR. Several states including New York, New Jersey, Connecticut, and Illinois are moving toward legalization, with New York alone projecting up to USD 1.7 billion in annual cannabis sales. Multiple cannabis companies including Weekend Unlimited Inc., iAnthus Capital Holdings, Neptune Wellness Solutions Inc., General Cannabis Corp., and Emblem Corp. have announced strategic expansions, new dispensary openings, licensing approvals, and product launches to capitalize on the sector's growth.